Results 261 to 270 of about 553,897 (314)
Some of the next articles are maybe not open access.
TREATMENT OF CHRONIC HEPATITIS
Gastroenterology Clinics of North America, 1992Chronic hepatitis is an etiologically diverse syndrome. The approach to treatment depends on the cause of the disease. The efficacy of immunosuppressive treatment of chronic autoimmune hepatitis has long been established, and most patients with this disease can be treated successfully with prednisone and azathioprine.
L, Lambiase, G L, Davis
openaire +2 more sources
Chronic Granulomatous Hepatitis
Australian and New Zealand Journal of Medicine, 1976Summary: Chronic granulomatous hepatitis.Three cases are described in which a chronic relapsing febrile illness was associated with granulomas in the liver. None of the known causes of hepatic granulomas was present in these patients. In two cases there was clinical improvement after corticosteroid treatment and this was associated with resolution of ...
Farrell G.C., Powell L.W.
openaire +5 more sources
Seminars in Diagnostic Pathology, 2006
Most liver biopsies performed today are for grading and staging of chronic viral hepatitis and steatohepatitis; there are uncommon indications for liver biopsy in the setting of acute hepatitis. Pathologists must have a broad knowledge of many forms of acute and chronic hepatitis, as well as their variations; these include viral hepatitis, autoimmune ...
Arief A, Suriawinata, Swan N, Thung
openaire +2 more sources
Most liver biopsies performed today are for grading and staging of chronic viral hepatitis and steatohepatitis; there are uncommon indications for liver biopsy in the setting of acute hepatitis. Pathologists must have a broad knowledge of many forms of acute and chronic hepatitis, as well as their variations; these include viral hepatitis, autoimmune ...
Arief A, Suriawinata, Swan N, Thung
openaire +2 more sources
Acta Paediatrica, 1973
SUMMARYIn a group of 35 children first classified as “chronic hepatitis”, the study of the histo‐logical patterns revealed only 16 cases as actual chronic hepatitis: 3 persistent nonaggres‐sive hepatitis (type l), 6 chronic aggressive hepatitis (type 2 a) and 7 chronic aggressive hepatitis (type 2 b).
D, Alagille +3 more
openaire +2 more sources
SUMMARYIn a group of 35 children first classified as “chronic hepatitis”, the study of the histo‐logical patterns revealed only 16 cases as actual chronic hepatitis: 3 persistent nonaggres‐sive hepatitis (type l), 6 chronic aggressive hepatitis (type 2 a) and 7 chronic aggressive hepatitis (type 2 b).
D, Alagille +3 more
openaire +2 more sources
Chronic hepatitis in haemophilia
Blood Reviews, 1993Chronic hepatitis affects almost all haemophiliacs treated with non-virally inactivated clotting factor concentrates. The virus responsible is hepatitis C (HCV) and most patients have non-neutralising antibodies with circulating virus. Although the majority also have evidence of past infection with hepatitis B, less than 5% are chronic carriers of ...
M, Makris, F E, Preston
openaire +2 more sources
Medical Clinics of North America, 1989
Chronic viral hepatitis is a common clinical problem; it must be differentiated from other forms of chronic liver disease by history, laboratory data, and liver biopsy. This article reviews the treatment of chronic hepatitis B, delta hepatitis, and nonA and nonB viral hepatitis and emphasizes the controlled trials when available.
G, Garcia, K R, Gentry
openaire +2 more sources
Chronic viral hepatitis is a common clinical problem; it must be differentiated from other forms of chronic liver disease by history, laboratory data, and liver biopsy. This article reviews the treatment of chronic hepatitis B, delta hepatitis, and nonA and nonB viral hepatitis and emphasizes the controlled trials when available.
G, Garcia, K R, Gentry
openaire +2 more sources
Pathology of Chronic Hepatitis B and Chronic Hepatitis C
Clinics in Liver Disease, 2010Histologic evaluation of the liver is a major component in the medical management and treatment algorithm of patients with chronic hepatitis B (HBV) and chronic hepatitis C (HCV). Liver biopsy in these patients remains the gold standard, and decisions on treatment are often predicated on the degree of damage and stage of fibrosis. This article outlines
openaire +2 more sources
The American Journal of Digestive Diseases, 1964
The etiology of chronic persistent hepatitis is not known. The evidence to date supports the view that subacute hepatic necrosis, rather than the ordinary epidemic viral hepatitis, can and does progress into chronic persistent hepatitis and postnecrotic cirrhosis. Glucocorticoid therapy results in clinical and biochemical improvements. If its long-term
openaire +2 more sources
The etiology of chronic persistent hepatitis is not known. The evidence to date supports the view that subacute hepatic necrosis, rather than the ordinary epidemic viral hepatitis, can and does progress into chronic persistent hepatitis and postnecrotic cirrhosis. Glucocorticoid therapy results in clinical and biochemical improvements. If its long-term
openaire +2 more sources
Chronic Hepatitis in Hemophilia
Scandinavian Journal of Haematology, 1977The relationship of chronic hepatitis B and/or liver dysfunction to treatment in 113 hemophiliacs was evaluated by the enzyme tests, SGOT and SGPT, and by the presence of circulating hepatis B surface antigen (HbsAg) or antibody (anti‐Hbs). The hemophiliacs were divided into three groups according to treatment pattern.
U, Hasiba, J A, Spero, J H, Lewis
openaire +4 more sources
Current Treatment Options in Gastroenterology, 2004
Interferon alpha, lamivudine, and adefovir are the three drugs currently approved for the treatment of chronic hepatitis B virus (HBV). There are pros and cons associated with the use of each drug. Individualization of therapy, based upon factors such as patient comorbidities, response to prior therapies, and stage of disease, is recommended.
Stephanie D, Straley, Norah A, Terrault
openaire +2 more sources
Interferon alpha, lamivudine, and adefovir are the three drugs currently approved for the treatment of chronic hepatitis B virus (HBV). There are pros and cons associated with the use of each drug. Individualization of therapy, based upon factors such as patient comorbidities, response to prior therapies, and stage of disease, is recommended.
Stephanie D, Straley, Norah A, Terrault
openaire +2 more sources